Making Cardiomyocytes from Pluripotent Stem Cells

Peter Karagiannis1, Yoshinori Yoshida2

  • 1Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Summary

Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) offer promise for heart disease research and therapies. However, challenges remain in optimizing their electromechanical properties, tissue integration, and genetic manipulation for studying heart disorders.